Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1

for the IMPAACT 2019 Study Team

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1877-1891
Number of pages15
JournalInfectious Diseases and Therapy
Volume13
Issue number8
DOIs
StatePublished - Aug 2024
Externally publishedYes

ASJC Scopus Subject Areas

  • Microbiology (medical)
  • Infectious Diseases

Keywords

  • Abacavir
  • Dolutegravir
  • HIV-1
  • Lamivudine
  • Pediatrics
  • Population pharmacokinetics

Cite this